NCT06297837

Brief Summary

The goal of this study is to improve the way urinary tract infections (UTIs) are tested for antibiotic resistance. The main questions it aims to answer are:

  • Can the investigators use a method called Bayesian causal inference to create or check clinical prediction models that help predict if certain antibiotics will work for a urinary infection, using patient information from the National Health Service (NHS)?
  • Can this new ADAPT-AST method, which uses data and a smarter approach, do a better job of testing for urinary infection than the old methods? Will it help doctors make quicker decisions and save resources by being more efficient? Participants in this study will not be receiving treatments. The study will involve: Using statistical methods to predict UTI test results based on patient data. Evaluating whether this new approach can provide doctors with more timely and useful information for treating UTIs. Assessing whether it can help save money and resources in the lab and pharmacy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 7, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

February 4, 2025

Status Verified

November 1, 2024

Enrollment Period

1.2 years

First QC Date

February 8, 2024

Last Update Submit

January 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The overall number of susceptible results per panel available at day 1

    The overall number of susceptible results per panel available at day 1

    2 years

Secondary Outcomes (7)

  • The number of susceptible results per panel available for WHO AWaRe Access category agents at day 1

    2 years

  • The number of susceptible results per panel for orally-administrable agents available at day 1

    2 years

  • The number of susceptible results per panel for intravenously-administrable agents available at day 1

    2 years

  • The proportion of panels with no results available for WHO AWaRe Access category agents at day 1

    2 years

  • The proportion of panels with no susceptible results of any kind available at day 1

    2 years

  • +2 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a suspected Urinary Tract Infection

You may qualify if:

  • o The specimens for which AST predictions \& recommendations will be made are urine specimens processed by LCL Microbiology laboratory taken from patients ≥ 18 years old in LUHFT and/or GP locations that grew organisms within the period of the study dataset; these are the only specimens for which AST results will be available to train and test ADAPT-AST. Predictions will be made for all urine specimen types, including mid-stream urines, catheter specimens of urine and nephrostomy urine.

You may not qualify if:

  • Urine specimens processed by LCL that did not grow organisms within the period of the study dataset
  • Urine specimens taken from patients \< 18 years old
  • Predictions will be made for asymptomatic bacteriuria screening specimens in pregnant women who have had specimens sent from a GP, but not those which have been sent from Liverpool Womens' NHS Foundation Trust (LWfT) Predictions for non-bacterial organisms grown in urine (i.e., fungi) will not be made.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liverpool University Hospitals NHS Foundation Trust

Liverpool, North West, United Kingdom

Location

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2024

First Posted

March 7, 2024

Study Start

September 1, 2024

Primary Completion

December 1, 2025

Study Completion

March 1, 2026

Last Updated

February 4, 2025

Record last verified: 2024-11

Locations